基于纳米粒子的药物输送用于血管应用.
Atanu Naskar1, Sreenivasulu Kilari1, Gaurav Baranwal1
1Vascular and Interventional Radiology Translational Laboratory, Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Bioengineering (Basel, Switzerland)
|January 8, 2025
概括
本综述探讨了用于血管治疗的纳米粒子 (NP) 药物递送系统. 它涵盖了NP类型,血液中的行为,以及针对改善治疗的向策略.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于纳米粒子 (NP) 的药物递送系统利用纳米材料的特性进行先进的治疗.
- 各种NP类型,包括脂质,PLGA,无机,碳,2D和仿生NP,都被用作药物载体.
研究的目的:
- 审查定制的NP用于血管内药物输送.
- 讨论血管内的纳米粒子行为 (边缘化,粘附,内皮吸收).
- 检查纳米材料兼容性和细胞表面蛋白质向性,以有效的血管药物输送.
主要方法:
- 基于NP的血管药物递送系统的综合文献综述.
- 对纳米粒子物理化学性质和血管系统内的相互作用进行分析.
- 评估涉及细胞表面蛋白质结合的向策略.
主要成果:
- 详细概述了各种适用于静脉注射的NP类型.
- 描述NP行为,包括边缘化,粘附和内皮细胞的吸收.
- 确定关键的细胞表面蛋白质点,以提高药物输送的精度.
结论:
- 纳米粒子设计和理解它们的血管行为对于有效的药物输送至关重要.
- 通过蛋白质结合的向输送为血管治疗提供了显著的潜力.
- 解决局限性和挑战对于将基于NP的血管药物输送转化为临床实践至关重要.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...


